In 2023, China was the leading exporter of glands and other organs for organo-therapeutic uses, far exceeding other countries, with a value of 1.4322 billion USD. The United States and France followed, albeit with negative growth of -4.73% and -2.02%, respectively. Notable year-on-year growth was observed in Saudi Arabia and Slovakia due to significant export increases of 115.98% and 23.19%, respectively. Meanwhile, Canada and Hungary faced substantial declines, with decreases of -16.36% and -16.8%, respectively, affecting their global standings.
Future trends to watch include the potential for increased demand in Asian and Eastern European markets, driven by advancements in biotechnology and healthcare sectors. These shifts may lead to more diverse suppliers emerging or growing stronger in these regions. Additionally, sustainability and regulatory changes could impact market dynamics, promoting innovative and sustainable practices in organo-therapeutic applications.
Top countries in Export of Glands and Other Organs for Organo-Therapeutic Uses by Country
| # | 10 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 1,432,200,000 | 2023 | +3.13% | +2.1% | View data |
| 2 | 2 United States | 440,950,000 | 2023 | -7.17% | -4.73% | View data |
| 3 | 3 France | 431,010,000 | 2023 | -0.54% | -2.02% | View data |
| 4 | 4 Singapore | 386,670,000 | 2023 | -2.45% | -4.17% | View data |
| 5 | 5 Netherlands | 234,250,000 | 2023 | +4.58% | +4.03% | View data |
| 6 | 6 Ireland | 224,380,000 | 2023 | +3.47% | +0.77% | View data |
| 7 | 7 United Kingdom | 197,330,000 | 2023 | +4.37% | +20.68% | View data |
| 8 | 8 Germany | 147,410,000 | 2023 | +1.31% | -1.36% | View data |
| 9 | 9 Sweden | 138,370,000 | 2023 | +0.71% | -0.25% | View data |
| 10 | 10 Italy | 99,503,000 | 2023 | +2.1% | +1.37% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
